Ming-Wei Kao

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Squamous Cell Carcinoma

Top Venues

International journal of molecular sciences

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Ming-Wei Kao, Yao-Hung Kuo, Kun-Chou Hsieh, Ching-Tai Lee, Shih-Chi Wu, Wen-Chi Yang
Immune Checkpoint Inhibitor, Nivolumab, Combined with Chemotherapy Improved the Survival of Unresectable Advanced and Metastatic Esophageal Squamous Cell Carcinoma: A Real-World Experience. International journal of molecular sciences 24 (8) (2023)
Ming-Wei Kao, Yao-Hung Kuo, Kun-Chou Hsieh, Ching-Tai Lee, Shih-Chi Wu, Wen-Chi Yang
Immune Checkpoint Inhibitor, Nivolumab, Combined with Chemotherapy Improved the Survival of Unresectable Advanced and Metastatic Esophageal Squamous Cell Carcinoma: A Real-World Experience. International journal of molecular sciences 24 (8) (2023)
Ming-Wei Kao, Yao-Hung Kuo, Kun-Chou Hsieh, Ching-Tai Lee, Shih-Chi Wu, Wen-Chi Yang
Immune Checkpoint Inhibitor, Nivolumab, Combined with Chemotherapy Improved the Survival of Unresectable Advanced and Metastatic Esophageal Squamous Cell Carcinoma: A Real-World Experience. International journal of molecular sciences 24 (8) (2023)
Ming-Wei Kao, Yue-Chiu Su, Peir-In Liang, Yi-Ying Wu, Tse-Ming Hong
Low Galectin-3 Expression Level in Primary Tumors Is Associated with Metastasis in T1 Lung Adenocarcinoma. Journal of clinical medicine 9 (6) (2020)